Cova322 (Anti-IL-17 & TNF-Alpha)
£485.25
Product
| Cat # A4043-1mg | Size 1mg |
Price
£485.25
|
Qty
|
Description
Cova322 is a bispecific FynomAb targeting TNF and IL-17A, created by fusing a small anti-IL-17A Fynomer to the anti-TNF antibody adalimumab. It shows potent inhibition of TNF and IL-17A in vitro and in vivo, offering potential benefits for inflammatory disease treatment. M.W 161.9 kDa.
Specifications
| Product Size | 1mg |
|---|---|
| Manufacturer Cat# | A4043 |
| Target | TNF-alpha |